Daysha Robinson

Contributions

Interleukin (IL)-5/IL-5-Receptor Antibodies Treat Severe Eosinophilic Asthma and COPD

Anti-IL-5/anti-IL-5R antibody therapy is highly clinically successful in treating severe eosinophilic asthma (SEA), and SEA and chronic obstructive pulmonary disease (COPD), but not in COPD alone. Interleukin-5/interleukin-5-receptor (IL-5/IL-5R) antibodies are anti-eosinophilic medications that have shown effectiveness for individuals with severe eosinophilic asthma (SEA). However, it has not been proven clinically effective for COPD patients. This...

Cost-Effectiveness of Omega-3 or Vitamin D for Sickle Cell Disease Crises

As additional treatments for painful crises in juvenile sickle cell disease, vitamin D and omega-3 could result in overall cost savings and therapeutic benefits. Painful crises are the most prevalent complication of sickle cell disease (SCD). Omega-3 and vitamin D were found to have a possible therapeutic effect on painful crises. This research was published...

Asthma Disparities Persist Despite Affluence Among Black and Hispanic Children

This study finds that Black and Hispanic children have consistently higher rates of asthma than White children, even in more affluent neighborhoods, indicating that factors beyond poverty and low socio-economic status are associated with racial disparities in asthma. A large, multi-institutional and longitudinal study led by the University of Wisconsin School of Medicine and Public...

Health Equity Index Reveals SDOH Linkages in Childhood Asthma

In response to a need for standardizing measurement and tracking of health equity outcomes in childhood asthma, researchers created a health equity index that re-envisions how equity-related data and metrics are collected. A recent grant-funded pilot project at Rady Children’s Health Network (RCHN) in Rancho Santa Fe, California, developed a dashboard that can help reduce...

Domains of Health Disparities in Asthma

Disparities in childhood asthma among racial and ethnic minorities are examined through five domains: socio-cultural, biological, built environment, behavioral, and health systems. Introduction Asthma is a heterogeneous disease that causes inflammation in the respiratory airways, impacts over 25 million Americans, and can lead to permanent airway obstruction and death. Asthma has been shown to disproportionately...

Ketamine Administration For Acute Painful Sickle Cell Crisis

In terms of pain relief, the ketamine-based regimen was not determined to be superior to the morphine-based regimen. Nevertheless, ketamine therapy was related to a considerable decrease in cumulative opioid dose. Sickle cell disease (SCD) is an inherited hematologic illness in which deoxygenated hemoglobin polymerizes, causing red blood cells to assume a sickle-like shape. These...

Digital Pain Self-Management Use Among Sickle Cell Patients and Caregivers

iCanCope is a digital pain self-management platform that helps patients and caregivers easily manage pain episodes. It has been shown to help reduce the frequency and severity of SCD pain episodes. In addition, it can also help improve the quality of life for both patients and caregivers. Sickle cell disease (SCD) is a group of...

Understanding the Efficacy of Phototherapy for Vitiligo

Phototherapy is one of the most effective ways to treat vitiligo. This study analyzed the efficacy of phototherapy in detail, in particular as it relates to combination therapies. When treating patients with vitiligo, healthcare providers can utilize various therapeutic options, including surgical techniques, drugs, and phototherapy. Among the different wavelengths of phototherapy available, narrowband UVB...

A Review of the Efficacy of Inebilizumab In Patients With NMOSD

Inebilizumab, a newly approved medication for NMOSD, is determined to be effective at limiting relapses. However, there are some limitations regarding which patients may benefit. Among patients with neuromyelitis optica spectrum disorder (NMOSD), a significant percentage are anti-aquaporin-4 (AQP4) antibody seropositive. Inebilizumab is a monoclonal antibody treatment that targets the B cell antigen CD19 in...
<< >>

Categories

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.